ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p813.xmlThe Greatest Show on Earth!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p813.pdf2026-04-18The Greatest Show on Earth!https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-pxxxvi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-pxxxvi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-plv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-plv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p815.xmlAdvances in the Care of Adult Patients With Acute Lymphoblastic Leukemia: Optimism Tempered by Reality2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p815.pdf2026-04-18Advances in the Care of Adult Patients With Acute Lymphoblastic Leukemia: Optimism Tempered by Realityhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p849.xmlAdherence to Hematologic Hold Parameters in Carboplatin and Dose-Dense Paclitaxel Chemotherapy for Ovarian Malignancies: A Survey of NCCN Member Institutions2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p849.pdf2026-04-18Adherence to Hematologic Hold Parameters in Carboplatin and Dose-Dense Paclitaxel Chemotherapy for Ovarian Malignancies: A Survey of NCCN Member Institutionshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p825.xmlNCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p825.pdf2026-04-18NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p837.xmlValue, Access, and Cost of Cancer Care Delivery at Academic Cancer Centers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p837.pdf2026-04-18Value, Access, and Cost of Cancer Care Delivery at Academic Cancer Centershttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p820.xmlWhole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p820.pdf2026-04-18Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p859.xmlThe Current State of Palliative Care for Patients Cared for at Leading US Cancer Centers: The 2015 NCCN Palliative Care Survey2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p859.pdf2026-04-18The Current State of Palliative Care for Patients Cared for at Leading US Cancer Centers: The 2015 NCCN Palliative Care Surveyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p867.xmlCare and Outcomes of Patients With Cancer Admitted to the Hospital on Weekends and Holidays: A Retrospective Cohort Study2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p867.pdf2026-04-18Care and Outcomes of Patients With Cancer Admitted to the Hospital on Weekends and Holidays: A Retrospective Cohort Studyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p875.xmlBone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p875.pdf2026-04-18Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p882.xmlPrevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p882.pdf2026-04-18Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p915.xmlCannabinoids for Symptom Management and Cancer Therapy: The Evidence2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p915.pdf2026-04-18Cannabinoids for Symptom Management and Cancer Therapy: The Evidencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p925.xmlPredictive Biomarkers for Molecularly Targeted Therapies in Renal Cell Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/7/article-p925.pdf2026-04-18Predictive Biomarkers for Molecularly Targeted Therapies in Renal Cell Carcinoma